A very solid update -
Based on the 6 million month you would have to think an annual sales of $60 million is now a base run rate annually.
Good solid product pipeline extension with MTX a technology base we know how to efficiently manufacture and a product surgeons want to use . A plus on top of $60 million.
Good geographic expansion on track in new big markets- A plus on top of $60 million.
With strong management and margins feeling very confident.
Ann: NovoSorb MTX First Sales and March 2023 $6m Revenue, page-21
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.040(1.57%) |
Mkt cap ! $1.781B | |||
| Open | High | Low | Value | Volume |
| $2.56 | $2.59 | $2.53 | $3.881M | 1.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10150 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 38947 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |